Clinical Trial Update: Efficacy Study of PAD and TAD in Newly Diagnosed Multiple Myeloma [Phase 4]

View source ↗

Summary

Clinical trial update for a Phase 4 efficacy study comparing PAD and TAD regimens in newly diagnosed multiple myeloma; the status or results are not provided.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Bortezomib (bortezomib)
• DEXAMETHASONE (Dexamethasone)
• Doxorubicin (doxorubicin)
• Thalidomide (thalidomide)

Snippet

Sponsor: Second Military Medical University | Conditions: Multiple Myeloma | Phase 4 | Status: UNKNOWN